Wuchterl Donald A. 4

What Happened

Donald A. Wuchterl, a director of Abeona Therapeutics, sold 14,814 shares on February 2, 2026. The reported weighted-average sale price was $5.09, generating gross proceeds of approximately $75,412. The filing notes the sale was made to cover tax obligations associated with the vesting of restricted stock awards, so this was a tax-withholding sale rather than a discretionary investment sale.

Key Details

• Transaction date: 2026-02-02 (Form 4 filed same day).
• Transaction type/code: Sale (S) — open market or private sale.
• Price: Weighted average $5.09; individual trades ranged from $5.09 to $5.12.
• Shares sold: 14,814; proceeds ≈ $75,412.
• Shares owned after the transaction: Not disclosed in the information provided in this summary.
• Footnotes: F1 — sale to cover tax obligations from restricted stock vesting; F2 — weighted-average price with trade range $5.09–$5.12 and offer to furnish per-price breakdown on request.
• Timeliness: The Form 4 lists the report and transaction date as 2026-02-02, indicating a timely filing.

Context

Sales to cover tax withholding on vested restricted stock are common and generally reflect tax-management, not necessarily a change in insider sentiment. For retail investors, purchases by insiders tend to be more informative about confidence; this transaction appears to be routine tax-related selling by a director.